Experience of Palliative Radiotherapy for Tumor-Associated Bleeding From Biliary Tract Cancer

Hideaki Kawabata, Misuzu Hitomi, Yoshiki Yamamoto, Takashi Fujii, Naonori Inoue, Yukino Kawakatsu, Yuji Okazaki, Masatoshi Miyata, Shigehiro Motoi, Yoshihiro Shimizu

Abstract


We experienced two cases of palliative radiotherapy (RT) for tumor-associated bleeding from biliary tract cancer (BTC). Bleeding due to tumor invasion to the duodenum wall caused severe anemia that required a blood transfusion. Hemostatic RT with 30 Gy in 10 - 12 fractions was attempted. Hemostasis was achieved in both patients, and they were able to spend their remaining life at home with no restrictions of their oral intake. In addition, no adverse events were seen in any of the two patients after undergoing palliative RT. Palliative RT for tumor-associated bleeding from BTC is suggested not only to be an effective and safe treatment option, but to improve the patient’s quality of life. The further accumulation of cases will be required in order to confirm the usefulness of hemostatic RT for BTC.




J Med Cases. 2018;9(10):328-331
doi: https://doi.org/10.14740/jmc3064e

Keywords


Biliary tract cancer; Bleeding; Hemostasis; Palliative radiotherapy; Quality of life

Full Text: HTML PDF
 
Browse  Journals
     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.